Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to ≥10% weight reduction with concomitant Taltz and ...

As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...

What Can I Eat on Tirzepatide for Weight Loss? This article was reviewed by Lynn Marie Morski, MD, JD. There isn’t a strict tirzepatide diet plan you need to follow. Instead, eat a variety of whole ...

Tirzepatide starts working quickly. You might notice less hunger in a few days or weeks. Average weight loss in 3 weeks is about 8 pounds for some people. How long it takes for tirzepatide to work ...

MENLO PARK, Calif.--(BUSINESS WIRE)--#OrsoBio--OrsoBio, Inc. (“OrsoBio” or “the Company”), a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic disorders, ...

(RTTNews) - Caliway Biopharmaceuticals (6919.TW) yesterday announced preclinical results evaluating its investigational drug CBL-514 in combination with Eli Lilly's dual GLP-1/GIP receptor agonist ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...